Language selection

Search

Details for: AVONEX

Company: BIOGEN CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02269201AVONEXINTERFERON BETA-1A30 MCG / 0.5 MLSOLUTIONINTRAMUSCULAR
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - AVONEX (interferon beta-1a) - Assessing the Potential Risk of Kidney Damage (nephrotic syndrome)
Summary Safety Review - Interferon beta products - Assessing the Potential Risk of Pulmonary Arterial Hypertension
Summary Safety Review - AVONEX (interferon beta-1a) - Assessing the Potential Risk of Kidney Damage (nephrotic syndrome)
Summary Safety Review - Interferon-beta Products - Thrombotic Microangiopathy
Summary Safety Review - AVONEX (interferon beta-1a) - Assessing the Potential Risk of an Inflammatory Disease that Affects One or More Organs (Sarcoidosis)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: